Pathways of Nucleocytoplasmic Transport
Pathways of Nucleocytoplasmic Transport
批准号:
7935045
负责人:
Bryce Paschal
金额:
$11.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-04-30
关键词:
AddressAffectAlanineAndrogen AntagonistsAndrogen ReceptorAndrogensAntibodiesBindingBiologyCell NucleusCellsCellular biologyChemicalsCoculture TechniquesCollaborationsCytoplasmDefectDiagnostic Neoplasm StagingDiseaseEukaryotaFamilyGenesGlobal ChangeGrowthGuanosine TriphosphateGuanosine Triphosphate PhosphohydrolasesHydrolysisIn VitroIndividualKnock-outLNCaPLaboratoriesLigand BindingLigandsMAPK14 geneMAPK8 geneMalignant neoplasm of prostateMammalsMass Spectrum AnalysisMassachusettsMediatingMitogen-Activated Protein KinasesModelingMolecularMutationN-terminalNuclearNuclear ExportNuclear ImportNuclear ReceptorsNucleotidesPC3 cell linePathway interactionsPatientsPhosphorylationPhosphorylation SitePhosphotransferasesPlasmidsPlayPost-Translational Protein ProcessingProcessProstateProstate Cancer therapyProtein BiosynthesisProteinsReagentRegulationResearch PersonnelRoleRunningSignal TransductionSignal Transduction PathwaySiteSmall Interfering RNAStressSystemTestingTumor stagebasebone cellcancer cellhormone therapyin vivoinhibitor/antagonistinsightintercellular communicationmembermitogen-activated protein kinase p38nuclear transport factor 2nucleocytoplasmic transportprotein complexreceptorreceptor functionresponsetranscription factorupstream kinase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Controlling transcription factor activity by regulating nuclear and cytoplasmic localization is an important and evolutionarily conserved mechanism. Members of the nuclear receptor (NR) super-family of ligand regulated transcription factors undergo cycles of nuclear import and export. We have found that nuclear export of the androgen receptor (AR) in prostate cancer cells is regulated by phosphorylation. Alanine mutations in two of the seven sites that undergo androgen-induced phosphorylation cause a defect in AR export to the cytoplasm. One site that regulates AR export (Ser308) is in the N-terminal domain. The other site (Ser650) is in the hinge region of AR, proximal to the DMA binding domain that functions as a nuclear export signal. We generated a panel of AR phosphosite-specific antibodies and found that Ser650 is phosphorylated by the stress-activated MAP kinase p38 in vitro and in vivo. We found that hyperosmolarity induces AR redistribution from the nucleus to the cytoplasm. This AR redistribution to the cytoplasm can be blocked by alanine mutations in AR phosphorylation sites, does not require new protein synthesis or the export receptor Crm1, and is reversible. The hypothesis of this proposal is that multiple signal transduction pathways activated by environmental stress regulate the process of nucleocytoplasmic transport. In Aims 1 and 2 we will identify the stress kinase pathways (p38, JNK, ERK) that regulate AR redistribution, determine if the AR redistribution is due to stimulation of nuclear export or inhibition of import, and determine the contributions of individual kinases using inhibitors, siRNA, and knockout cells. In addition to regulating the localization of AR, stress signaling exerts global effects on the nuclear transport machinery by disrupting the Ran gradient which is essential for most nuclear transport pathways. In Aim 3 we will determine whether Ran gradient disruption involves stress signaling to factors that control Ran transport or the Ran GTPase cycle. Our studies will provide new insight into the mechanisms that mediate crosstalk between signal transduction, nuclear transport, and NR activity.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
NXT1 is necessary for the terminal step of Crm1-mediated nuclear export.
NXT1对于CRM1介导的核出口的终端步骤是必需的。
DOI:
10.1083/jcb.152.1.141
发表时间:
2001-01-08
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Black BE, Holaska JM, Lévesque L, Ossareh-Nazari B, Gwizdek C, Dargemont C, Paschal BM]
通讯作者:
Paschal BM
Scientists share nuclear secrets at Jekyll Island.
科学家们分享杰基尔岛的核秘密。
DOI:
10.1111/j.1600-0854.2006.00417.x
发表时间:
2006
期刊:
Traffic (Copenhagen, Denmark)
影响因子:
--
作者:
[Pemberton,LucyF, Paschal,BryceM]
通讯作者:
Paschal,BryceM
DOI:
10.1083/jcb.152.1.127
发表时间:
2001-01-08
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Holaska JM, Black BE, Love DC, Hanover JA, Leszyk J, Paschal BM]
通讯作者:
Paschal BM
Training in Cell and Molecular Biology
-
批准号:10427127
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2021
-
负责人:Bryce Paschal
-
依托单位:
Training in Cell and Molecular Biology
-
批准号:10631060
-
项目类别:
-
资助金额:$42.44万
-
财政年份:2021
-
负责人:Bryce Paschal
-
依托单位:
Parp Function in Prostate Cancer
-
批准号:10091413
-
项目类别:
-
资助金额:$35.43万
-
财政年份:2017
-
负责人:Bryce Paschal
-
依托单位:
Parp Function in Prostate Cancer
-
批准号:9285034
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2017
-
负责人:Bryce Paschal
-
依托单位:
Parp Function in Prostate Cancer
-
批准号:10582213
-
项目类别:
-
资助金额:$46.87万
-
财政年份:2017
-
负责人:Bryce Paschal
-
依托单位:
Regulation of nuclear transport in disease
-
批准号:9036926
-
项目类别:
-
资助金额:$32.14万
-
财政年份:2012
-
负责人:Bryce Paschal
-
依托单位:
Regulation of nuclear transport in disease
-
批准号:8829120
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2012
-
负责人:Bryce Paschal
-
依托单位:
Regulation of nuclear transport in disease
-
批准号:8448628
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2012
-
负责人:Bryce Paschal
-
依托单位:
Regulation of nuclear transport in disease
-
批准号:8291575
-
项目类别:
-
资助金额:$31.31万
-
财政年份:2012
-
负责人:Bryce Paschal
-
依托单位:
Regulation of nuclear transport in disease
-
批准号:8664768
-
项目类别:
-
资助金额:$32.15万
-
财政年份:2012
-
负责人:Bryce Paschal
-
依托单位:
Nuclear Transport of Androgen Receptor
-
批准号:7728882
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2008
-
负责人:Bryce Paschal
-
依托单位:
Signaling and Progression in Prostate Cancer
-
批准号:8338790
-
项目类别:
-
资助金额:$174.13万
-
财政年份:2005
-
负责人:Bryce Paschal
-
依托单位:
Project 2
-
批准号:8744394
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2005
-
负责人:Bryce Paschal
-
依托单位:
Project 2
-
批准号:8744371
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2005
-
负责人:Bryce Paschal
-
依托单位:
Core A
-
批准号:8744396
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2005
-
负责人:Bryce Paschal
-
依托单位:
Project 2
-
批准号:8916610
-
项目类别:
-
资助金额:$33.13万
-
财政年份:2005
-
负责人:Bryce Paschal
-
依托单位:
Signaling and Progression in Prostate Cancer
-
批准号:8720703
-
项目类别:
-
资助金额:$178.23万
-
财政年份:2005
-
负责人:Bryce Paschal
-
依托单位:
Signaling and Progression in Prostate Cancer
-
批准号:8543649
-
项目类别:
-
资助金额:$171.99万
-
财政年份:2005
-
负责人:Bryce Paschal
-
依托单位:
Signaling and Progression in Prostate Cancer
-
批准号:7664462
-
项目类别:
-
资助金额:$181.75万
-
财政年份:2005
-
负责人:Bryce Paschal
-
依托单位:
Signaling and Progression in Prostate Cancer
-
批准号:8081262
-
项目类别:
-
资助金额:$184.44万
-
财政年份:2005
-
负责人:Bryce Paschal
-
依托单位:
海外基金